First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Our employees’ unwavering dedication to continuous improvement and quality assurance lies at the heart of our customer-centric approach, utilizing
Will GLP-1 weight loss drugs become more prevalent in workers’ compensation? Glucagon-like peptide 1 (GLP-1)
As the workers' compensation and auto industry braces itself for the regulatory changes sweeping across Michigan, Florid
Beyond convenience, reliable transportation prevents missed appointments that can delay recovery and worsen health outcomes.
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part